Alpha Cancer Technologies Inc., (ACT) is a private clinical stage biotechnology company with products under development in oncology and auto-immune disease indications. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP) with unique immuno-oncology properties.One of the largest US biotech companies recently purchased a 14% equity stake in ACT for US $7.5 million as part of a larger financing with institutional and private investors.
Our primary strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. In addition to building an efficient in-house clinical development organization with regulatory and data management capabilities, Spectrum has established a commercial infrastructure for itsmarketed products. We have two oncology products on the market, one for low-grade or follicular non-Hodgkin's lymphoma and one for advanced metastatic colorectal cancer, as well as two drugs in late stage development: apaziquone and belinostat, along…
ABOUT MEDICUREMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.Medicure's core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT. Acquired in 2006, AGGRASTAT is experiencing renewed interest from hospitals and clinicians in the US due to its compelling clinical and economic evidence. The Company has an experienced commercial team dedicated exclusively to the marketing of AGGRASTAT.AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary…
About UsVisionSynageva BioPharma is a clinical stage biopharmaceutical company dedicated to discovering, developing and delivering medicines for patients with rare disease and unmet medical need. At Synageva, we share a passion and commitment to improving the lives of patients with rare diseases. Our team is drawn from leading biotech companies and has helped bring several life-saving therapies to patients whose diseases were once considered too rare for developing treatments. We believe that every patient deserves treatment options, regardless of the rarity of their disease.ProgramsOur lead…
Alba Biologics Group is a leading biopharmaceutical strategic and technical support group providing consulting and management services to start-ups, early product developers and established industry leaders. With 20 years experience Alba Biologics leverages the expertise of the founder and our associates to help clients advance drug candidates from the bench through to regulatory approval. Alba will support client organizations on both short and long term projects working with a clientпїЅs in house staff as well as integrating with contract service providers.Alba Biologics brings to the…
OverviewFibeRio Technology Corp. ("FibeRio" or the "Company") has developed revolutionary Forcespinning™ technology to produce nanofibers at commercial scale. This Forcespinning approach has the potential to replace 50+ year old electrospinning technology which is an order of magnitude less productive, over 4x more expensive, limiting in terms of materials and volume capabilities, and results in hazardous waste and disposal issues. The market and applications for nanofibers is expected to grow dramatically over the next 10 years across almost every industry (filtration, energy, textiles,…
Novasep is a leading provider of services in the field of molecule production and purification for the life science and chemical industries, based on an unrivalled pool of specialized technologies.
Lydall, Inc. (NYSE: LDL) designs and manufactures specialty engineered products for thermal/acoustical, filtration/separation, and bio/medical applications.The Performance Materials segment offers filtration media solutions for air, fluid power, industrial, and life science applications; and industrial thermal insulation solutions, such as nonwoven veils, papers, mats, and specialty composites for the building products, appliance, and energy and industrial markets. The Vital Fluids segment offers products for cryogenic storage, blood transfusion and cell therapy applications in the life…
Solabia Group: Converging Bio-Expertise and Sustainable Innovation. Having invested in the Cosmetics, Pharmaceutical, Nutritional, Diagnostics and Biotechnology sectors, Solabia benefits from a coherent ensemble of converging know-how that allows us to reach our goal : satisfy your needs! Our 5 Sectors: - Cosmetics - Pharmaceutical - Nutritional - Diagnostics - Biotechnology
Neuronasal develops drugs, delivered intranasally, for acute brain injuries. Our first products are for concussion. Neuronasal was founded to create value for patients and investors by licensing and developing drugs to treat acute brain injuries and disease. We plan to develop each of our drugs to proof of concept and then enter into strategic partnerships or trade sales. Neuronasal’s first two products are repurposed off patent drugs, deferoxamine and N acetyl cysteine, that we will deliver with existing intranasal delivery devices in clinical trials for concussion and intracerebral…
VBI Vaccines Inc. (Nasdaq: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus. The company’s lead eVLP asset is a prophylactic Cytomegalovirus (“CMV”) vaccine; VBI has initiated work for GMP manufacturing of its CMV candidate for use in formal preclinical and Phase I trials. The company’s second platform is a thermostable technology that enables the…
SBH Sciences, Inc. was founded in 1997 with the sole purpose of producing mammalian-derived recombinant cytokines. Today, we have drastically expanded our services to offer cytokine-measuring bioassays, in vitro anti-cancer and anti-inflammation lead drug development, as well as the development of ELISA kits and Multiplex analyses.In the last year, we have continued our diversification and through partnerships with several companies, our product line now includes specific enzymes, specific kinase activity analysis and in vivo cancer models.SBH Sciences has been an innovator in the…
Lipella Pharmaceuticals Inc. is a privately held development-stage biotechnology company dedicated to improve patient care by developing novel products which focus on trans-mucosal therapy, delivering local treatments directly to their site of action. Lipella focuses on four therapeutic areas: urology, otorhinolaryngology, gastroenterology, and dermatology. In each of these areas, Lipella has liposomal therapies in various stages of development ranging from pre-clinical to early clinical in the U.S. and overseas.
Reviticell is at the forefront of the regenerative medicine industry, a medical revolution that will forever change the way we treat, the way we heal – the way we restore lives. Reviticell is developing simple and effective therapeutic systems for physicians – each with an intuitive protocol for safely and effectively preparing a patient’s own blood or body fat to unlock the healing powers within. Reviticell's Stem-Cell Therapy Kits are being developed to treat various diseases and conditions such as Heart disease, Diabetes, Alzheimer’s, Leukemia, Lymphoma, Parkinson’s, just to name…
Suntec Corporation was established in 2005 in Southern California, USA. We engage in the business of biotech, medical device and drug development. With a few years of perseverance and persistence, we have experienced rapid growth and significant success in global leadership of pharmaceutical markets.
We solve PROBLEMS and fill unmet NEEDS in medicine, through next-generation medical device technologies.At Aeon Technologies, we see VAST INEFFICIENCIES inherent in many medical technologies today, resulting in unmet needs, and immense OPPORTUNITIES open for those with breakthrough medical solutions. We have pioneered and created a whole portfolio of them, and are prepared to take dominant positions in billion-dollar markets.For example, worldwide per capita patient health care costs are spiraling out of control, more and more each year. The greatest culprit is not drug costs, but…
Innoveas International is a leading innovation company, transforming world class technologies and innovative scientific ideas from universities and public research Institutions in Germany into game-changing enterprises. The company invests in high impact innovations in the global healthcare, energy, digital and environmental sectors.
Versante International, LLC is a leader in providing Biometrics related services to the Pharmaceutical and Biotech clinical development stage companies. Our team of proven experts in Biostatistics, SAS Programming and Data Management has extensive experience across a wide range of therapeutic areas. Work with Versante and benefit from shorter development times, enhanced product quality and reduced regulatory review cycles.
Venture Development FirmInnovation TechnologyVenture Capital FormationStrategic Growth & RelationsAgile Accelerated DevelopmentBiotech, Life Science, Medical Device, Food/Agri/Aqua, Controls/Instruments, Software/Data, Cleantech
Epione Biopharmaceuticals was formed to provide the benefits of highly efficacious, injectable medications for the treatment of pain in multiple markets without the burden and risks that opiate-based therapies offer. The worldwide incidence of acute and chronic pain, and the growing occurrence of migraine have lead to widespread consequences for both the healthcare system and the economy. First-line pain treatments are typically opiate-based medications; however, concerns regarding side effects, prescription drug abuse, risk of overdose, patient non-adherence to treatment regimens…
